Showing results (61-70 of 107) with videos related to
Sort By:
Pageof 11
MMWR. Morbidity and Mortality Weekly Report|February 10, 2017
Vital Signs: Noise-Induced Hearing Loss Among Adults - United States 2011-2012Yulia I Carroll, John Eichwald, Franco Scinicariello, et al.Clinical Cardiology|April 13, 1999
Digital assessment of the epicardial electrocardiogram: novel methodology for a core laboratory for clinical studiesB E Bertolet, A F Boyette, E M Handberg-Thurmond, et al.Journal of Medicinal Chemistry|March 1, 1980
Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activityW E Kreighbaum, W L Matier, R D Dennis, et al.Research Square|November 14, 2023
A long-term fulvestrant eluting implant is safe, non-toxic, and reduces the risk of breast cancer in in vivo modelsScott Thomas, Elysia Roche, Pujan Desai, et al.Scientific Reports|January 23, 2025
Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implantScott Thomas, Elysia Roche, Pujan Desai, et al.Genes, Brain, and Behavior|February 27, 2009
Amygdala protein kinase C epsilon controls alcohol consumptionH M B Lesscher, M J Wallace, L Zeng, et al.Circulation|August 1, 1990
Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindololE J Eichhorn, J B Bedotto, C R Malloy, et al.Journal of the American College of Cardiology|May 1, 1991
Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathyJ L Anderson, E M Gilbert, J B O'Connell, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2020
Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIVDavid Gingrich, Amelia N Deitchman, Amy Kantor, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugsJacqueline P Ernest, Janice Jia Ni Goh, Natasha Strydom, et al.Pageof 11